Stay updated with breaking news from Seika Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On January 28, 2024, Celltrion USA announced that it has completed submission of its application to the FDA for CT-P47, its proposed tocilizumab biosimilar. CT-P47 references...
According to a January 2024 press release from Accord BioPharma, Inc. ("Accord"), the FDA accepted Accord's abbreviated Biologics License Application (aBLA)...
CSL achieves a global milestone as Japan approves ARCT-154, the first sa-mRNA COVID-19 vaccine, showcasing CSL's commitment to innovation, efficacy, and prolonged protection against variants. Jonathan Edelman, MD, senior VP of CSL Vaccine’s Innovation Unit, speaks with ICT.
According to a January 2024 press release from Accord BioPharma, Inc. (“Accord”), the FDA accepted Accord’s abbreviated Biologics License Application (aBLA) for DMB-3115 (ustekinumab),...
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The